PETMEDICA® DRIVES ITS EXPANSION WITH A STRATEGIC PRESENCE IN SOUTHEAST ASIAN COUNTRIES

Participation in both markets opens new business opportunities and consolidates the company as the only pharmaceutical company present in these key spaces for the development of the pet sector.

Lima, November 2025. Petmedica®, Agrovet Market®'s specialized companion animal line, continues to strengthen its expansion strategy toward Asia and the Middle East with a presence in Thailand and China, key markets for the internationalization of innovative veterinary solutions and the building of high-value commercial alliances. This presence reflects a sustained focus on developing strategic relationships that allow the company's portfolio to reach new, competitive, and rapidly growing markets.

In Bangkok, the company participated in PetFair SEA, the leading B2B event for the sector in the region, which brought together the most relevant players in the industry and facilitated meetings with strategic distributors seeking premium solutions backed by scientific evidence. Simultaneously, participation in the China International Pet Show (CIPS), the largest event in the Asia Pacific region, strengthened relationships with partners in key markets such as South Korea, India, the Philippines, Indonesia, and the United Arab Emirates. This allowed the company to further position itself and its Petmedica® line as trusted brands with globally competitive technological offerings.

Presence at both events helped accelerate commercial agreements and deepen the company's expansion into strategic territories, reinforcing its international standing and advancing the consolidation of a Peruvian veterinary offering with international standards.
Global Launch of Atrevia® 360

The launch of Atrevia® 360, winner of the 2025 Pet Innovation Award, generated significant interest among distributors and specialists due to its unique and differentiated formulation and its effectiveness in the field. The presence in Thailand and China served as the perfect showcase to position this product within the premium veterinary solutions segment.

Regarding these advancements, Umberto Calderón, CEO of Agrovet Market®, stated: “Our participation in these events confirms the path we have been forging as a company: bringing high-level veterinary innovation to the most demanding markets. We are proud to bring Peruvian innovation to the world and demonstrate that our solutions compete at the same level as renowned global brands.”

These actions solidify Agrovet Market®'s export-oriented nature and its position as the leading Peruvian exporter of veterinary medicine worldwide, reaffirming its role as a competitive player in global markets and its capacity to expand with a proposition based on innovation, scientific evidence, and international standards, thus strengthening its presence in strategic territories and contributing to the development of a veterinary industry with a global vision.